GLP1R agonists like lixisenatide, exenatide, or semaglutide limit the progression of motor dysfunction in Parkinson’s disease.
Lyxumia
Posted inMetabolism, New Drugs, Regulatory
Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus
Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.